首页>
外国专利>
IN VITRO ANTIBODY PERFUSION OF KIDNEY GRAFTS
IN VITRO ANTIBODY PERFUSION OF KIDNEY GRAFTS
展开▼
机译:肾移植物的体外抗体灌注
展开▼
页面导航
摘要
著录项
相似文献
摘要
In vitro treatment of a kidney prior to transplantation into a human recipient to reduce the risk of rejection, comprises perfusing the kidney with a solution of antibody specific to passenger leukocytes (e.g. anti-CD45 antibody) under cold ischaemia (CI) conditions with the renal vein occluded, and incubating the perfused kidney under CI conditions for at least 20 minutes. The volume of perfusion liquid is preferably at least 50 ml and the concentration of mAb about 40 mu g/ml or more. This has been found to increase mAb uptake by the target cells and the extent of mAb saturation of the target cells, and seems to be associated with a reduced incidence of graft rejection.
展开▼